Microvascular Therapeutics

Venture Madness selects 16 presenting companies for our annual capital conference & pitch competition! Finalists will present at the 2024 Venture Madness Conference to secure funding from accredited investors and earn prizes for their early-stage companies. Check out the presenting companies👉 Beyond Silicon Bold Street Boxxtech Cerebrum Clientship MealManage LLC Microvascular Therapeutics, Inc. Paramium Technologies Paxauris Preamble Privv Quibble Retisio Rovicare, Inc. Simplifyance Turn Medical https://lnkd.in/gTJnCAZP

🔥🔥 Brace yourselves for the sensational 2023 #H7 Healthcare Investment Forum & Demo Day happening on December 7th, 2023! 👏👏 Dive into an immersive experience, witnessing compelling presentations from the 2023 Cohort of H7 BioCapital's healthcare accelerator. It's your chance to engage with top-tier healthcare #VC investors, gaining unparalleled insights into life science and MedTech investment landscapes. 🔔 Sponsorship Callout 🔔 Elevate your brand's visibility by becoming a sponsor! Contact us at info@h7biocapital.com for sponsorship details. Act fast! Limited promotion packages ($400) and demo table packages ($600) are up for grabs! 💎 We are delighted to introduce our distinguished speakers: - Bill Reichert, General Partner, Pegasus Tech Ventures - Jian(Jay) Lin, Senior Director External Innovation DPDS, Johnson & Johnson - Mike Ryan, Managing Partner, MGR Capital - Gary Goldman MD, DDS, MBA, Founding Partner, Global Health Impact Fund - Neil Littman, Founder & Managing Director, Bioverge Ventures - Aditya Asokan, Investor, Samsara BioCapital - Nola E. Masterson E Masterson, Investor, Portfolios Femtech Fund - Paul Grewal, Partner, SIC Venture Studio - Brian💥 Sparkes, Head of Communication, Bay Angels - Robert E. "Bob" Sweeney, Cofounder, Global Health Impact Network - Harneet Bath, MD, VP, VEP Healthcare/USACS West Region 🍁 We have also confirmed these exciting pitching companies: • Cellicure, Inc., providing innovative cell-based immunotherapy technologies with a rich pipeline of products. • QuanMol Technology, an automated platform for drug optimization. • Microvascular Therapeutics, a clinical stage biopharma pioneering in ultrasound contrast agents and theranostics. • Novall, pioneering novel nitric oxide delivery devices targeting unmet needs in cardiopulmonary and antimicrobial medicine. ✏️Event Schedule: 12:00 pm - 1:00 pm: Registration & Networking with tantalizing food and drinks 1:00 pm - 1:10 pm: Welcome Notes 1:10 pm - 1:50 pm: Investment Panel: Biotech & Life Science Ventures 1:50 pm - 2:50 pm: Stellar Startup Pitches 2:50 pm - 3:10 pm: Coffee Break 3:10 pm - 3:30 pm: Keynote Address 3:30 pm - 4:10 pm: Investment Panel: MedTech Sector Investments 4:10 pm - 4:50 pm: Entrepreneur Panel: Navigating Success in Healthcare 4:50 pm - 5:00 pm: Closing Remarks 5:00 pm - 7:00 pm: Networking Extravaganza 🎯Secure your spot now! Register at https://shorturl.at/rvS58 Q. Frank Li, MD, PhD, Xingyu Shen, Emmanuelle J. Meuillet #healthcare #lifesciences #medtech #ai #fundraising #vc #tech #pitching #biotech #accelerator #venture #unicorn #exit #startup #entrepreneurship

Let's applaud the 15 NIH-funded companies that impressed investors with their life science innovations at last week's Life Science Summit. They come with NIH non-dilutive funding, setting the stage for incredible investments. Investors, your next ample #bitotech opportunity awaits! Learn more about America's Seed fund powered by NIH: https://seed.nih.gov/ Participating companies: Dignify Therapeutics, Microvascular Therapeutics, Kuda Therapeutics, RNA NanoTherapeutics, Stingray Therapeutics, Tezcat Biosciences, Vivreon Biosciences LLC, Epiodyne, Neurodon LLC, EicOsis, NovoMedix, 7 Hills Pharma, UNandUP, Neuropathix, Inc., Phoenix Nest Inc. #SBIR #STTR